
Today’s Yangtze funding roundup: AIDD, robotaxi, mining truck, AI chip…
Shanghai AI drugmaker Anew Labs raised $290 million in its first standalone funding round, valuing the company at $1.5 billion.

Shanghai AI drugmaker Anew Labs raised $290 million in its first standalone funding round, valuing the company at $1.5 billion.
The latest additions broaden that effort from drug and product information to medical knowledge and nutrition data.
Under a service model, customers pay for transportation capacity without having to own, insure or maintain the vehicles.
Through its partnership with Stellantis, Leapmotor International now has more than 1,000 sales and service outlets across 45 markets.
The essay offers an unusual glimpse into how AI automation is being perceived by engineers at the cutting edge of China’s AI industry.
The first vehicle rolling off the line less than a year after the partnership was signed highlights the speed of the approach.